Understanding Go-to-Market Strategies in the Generics Pharma Market
07/29/2025
One of our clients wants to connect with experts who have knowledge about the generics pharmaceutical market. They are trying to understand the go-to-market strategies used by foreign pharmaceutical companies entering new markets, particularly evaluating the trade-offs between building an in-house sales force versus leveraging third-party providers. The scope includes commercial strategies, market entry dynamics, salesforce models, and regulatory factors. The experts who have previously worked with prominent players such as Glenmark, Cipla, Dr. Reddy’s, Piramal, Sun Pharma, Lupin, and Aurobindo Pharma would be ideal.
